These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8832290)

  • 1. Expression and immunogenicity of the C-terminus of a major blood-stage surface protein of Plasmodium vivax, Pv200(19), secreted from Saccharomyces cerevisiae.
    Kaslow DC; Kumar S
    Immunol Lett; 1996 Jul; 51(3):187-9. PubMed ID: 8832290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax.
    Gibson HL; Tucker JE; Kaslow DC; Krettli AU; Collins WE; Kiefer MC; Bathurst IC; Barr PJ
    Mol Biochem Parasitol; 1992 Feb; 50(2):325-33. PubMed ID: 1371329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.
    Barr PJ; Gibson HL; Enea V; Arnot DE; Hollingdale MR; Nussenzweig V
    J Exp Med; 1987 Apr; 165(4):1160-71. PubMed ID: 3549959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax: cloning and expression of a major blood-stage surface antigen.
    del Portillo HA; Gysin J; Mattei DM; Khouri E; Udagama PV; Mendis KN; David PH
    Exp Parasitol; 1988 Dec; 67(2):346-53. PubMed ID: 3056739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
    Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
    Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180.
    Muh F; Han JH; Nyunt MH; Lee SK; Jeon HY; Ha KS; Park WS; Hong SH; Ahmed MA; Na S; Takashima E; Tsuboi T; Han ET
    Malar J; 2017 Mar; 16(1):133. PubMed ID: 28351409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
    Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and immunological properties of a viral hybrid particle expressing the Plasmodium vivax merozoite surface protein 1 C-terminal region.
    Wunderlich G; del Portillo HA
    Mol Med; 2000 Mar; 6(3):238-45. PubMed ID: 10965497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection.
    Cheng Y; Wang B; Changrob S; Han JH; Sattabongkot J; Ha KS; Chootong P; Lu F; Cao J; Nyunt MH; Park WS; Hong SH; Lim CS; Tsuboi T; Han ET
    Malar J; 2017 May; 16(1):211. PubMed ID: 28532483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).
    Alam MT; Bora H; Singh N; Sharma YD
    Vaccine; 2008 Jul; 26(31):3787-94. PubMed ID: 18579264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax.
    Park CG; Chwae YJ; Kim JI; Lee JH; Hur GM; Jeon BH; Koh JS; Han JH; Lee SJ; Park JW; Kaslow DC; Strickman D; Roh CS
    Am J Trop Med Hyg; 2000 Jun; 62(6):720-5. PubMed ID: 11304063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
    Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
    Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
    Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41.
    Cheng Y; Lu F; Tsuboi T; Han ET
    Acta Trop; 2013 Jun; 126(3):222-8. PubMed ID: 23499861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.
    Bastos MS; da Silva-Nunes M; Malafronte RS; Hoffmann EH; Wunderlich G; Moraes SL; Ferreira MU
    Clin Vaccine Immunol; 2007 Oct; 14(10):1249-59. PubMed ID: 17699838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720.
    Saul A; Hensmann M; Sattabongkot J; Collins WE; Barnwell JW; Langermans JA; Wu Y; Long CA; Dubovsky F; Thomas AW
    Parasite Immunol; 2007 Oct; 29(10):525-33. PubMed ID: 17883455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.